Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019 : an audit study from cellular pathology

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ..

AIMS: We performed an audit to evaluate the impact of the COVID-19 pandemic-related delay in the diagnosis of major cancers at a Pathology Unit of a Secondary Care Hospital Network in Italy.

METHODS: A comparison was made among the number of first cellular pathological diagnoses of malignancy made from the 11th to the 20th week of the years 2018-2020.

RESULTS: Cancer diagnoses fell in 2020 by 39% compared with the average number recorded in 2018 and 2019. Prostate cancer (75%) bladder cancer (66%) and colorectal cancer (CRC; 62%) had the greatest decrease. CRC was identified as carrying a potentially important diagnostic delay.

CONCLUSIONS: For CRC corrective procedures (continuing mass screening tests; patient triage by family physicians; diagnostic procedures alternative to colonoscopy; predictive evaluation on biopsy samples) were advised. Our simple audit model is widely applicable to avoid pandemic-related delay in clinical diagnosis of cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:74

Enthalten in:

Journal of clinical pathology - 74(2021), 3 vom: 19. März, Seite 187-189

Sprache:

Englisch

Beteiligte Personen:

De Vincentiis, Ludovica [VerfasserIn]
Carr, Richard A [VerfasserIn]
Mariani, Maria Paola [VerfasserIn]
Ferrara, Gerardo [VerfasserIn]

Links:

Volltext

Themen:

Clinical audit
Colorectal neoplasms
Diagnosis
Epidemiology
Infections
Journal Article

Anmerkungen:

Date Completed 24.02.2021

Date Revised 24.02.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1136/jclinpath-2020-206833

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM311401724